Generics New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to fund new brands of the potassium-sparing diuretic amiloride hydrochloride (Apo-Amiloride) and the ACE inhibitor perindopril (Apo-Perindopril) through an agreement with generic drugmaker Apotex NZ Limited; to alter the subsidy arrangement for the existing funded brand of perindopril (Coversyl, originated by France's Laboratories Servier); and to clarify the subsidy arrangement for trandolapril (Gopten, originated by Knoll, now part of Abbott Labs). In summary: 11 March 2013